about
A review of physiological and behavioral changes during pregnancy and lactation: potential exposure factors and data gaps.The management of acne vulgaris in pregnancy.Prenatal Developmental Toxicity Study of Glycosides-based Standardized Fenugreek Seed Extract in RatsEffect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant womenA meta-analysis of treatments for perinatal depression.Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.Leveraging physiological data from literature into a pharmacokinetic model to support informative clinical study design in pregnant women.Oxytocin and postpartum depression: delivering on what's known and what's not.Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.Antibiotic Treatment of Dogs and Cats during Pregnancy.Diabetes and hypertension increase the placental and transcellular permeation of the lipophilic drug diazepam in pregnant women.Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics.Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women.Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar Border.Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation.Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy.A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.Pharmacogenetics and other reasons why drugs can fail in pregnancy: higher dose or different drug?Measurement of betamethasone concentration in maternal serum treated for fetal lung maturity; Is it feasible?Pharmacokinetics of paracetamol and its metabolites in women at delivery and post-partum.Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant womenThe fate and effects of xenobiotics in human placenta.Vitamin D expenditure is not altered in pregnancy and lactation despite changes in vitamin D metabolite concentrationsAltered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymesRegulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol eliminationA randomised controlled trial comparing weight adjusted dose versus fixed dose prophylactic phenylephrine infusion on maintaining systolic blood pressure during caesarean section under spinal anaesthesia.A simplified PBPK modeling approach for prediction of pharmacokinetics of four primarily renally excreted and CYP3A metabolized compounds during pregnancyChanges in the rate of nicotine metabolism across pregnancy: a longitudinal study.Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.Medication utilization pattern for management of pregnancy complications: a study in Western Nepal.Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda.Pharmacokinetics in special populations.Cardiac drug use in pregnancy: safety, effectiveness and obstetric implications.Physiologic and pharmacokinetic changes in pregnancy.Maternal Pharmacokinetics and Fetal Disposition of (±)-Citalopram during Mouse Pregnancy.Systematic review of pregnancy in women with inherited cardiomyopathies.Pharmacokinetic optimization of antiretroviral therapy in pregnancy.Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.
P2860
Q30733648-049A7FC1-10E2-4E6D-BC7F-B815ECF0029AQ31135745-96EE564A-FCEB-4714-BE6E-190D49815A93Q33609164-2B219B6E-7769-4DE5-A6A8-4FB83383F5DDQ33869119-47458432-C453-4D33-9867-F32351656C1CQ33942240-98BC9DC9-EEDF-4A12-BC63-5A546E9DF6FAQ34034413-D23ECC32-7403-4019-AB0F-5EE03044C3CBQ34127900-3D99F557-17EC-4410-AEE8-45B4B42F496EQ34143400-3F73228D-3C2E-4FD1-885C-351A2CFCF7B0Q34331026-04258253-B49B-465A-A682-2377B3814B64Q34495464-81D9D6B4-1B7F-4357-AD3D-B2165DF47AD2Q35019769-21259719-22E2-48DA-B671-435303122D24Q35060812-6BE0C91E-DA3A-42D6-93B5-B4ADB60D5DFBQ35827743-6E1819E0-C1F3-4F16-8E8E-DDF30AEEE01AQ35867343-613FE08E-F67E-4906-87FA-52470A28E215Q36075976-8D43DC87-16A6-49E4-97D6-38140452BEF4Q36125445-57BF2813-5BC2-442A-B133-38893108F60FQ36187641-2907D3C7-8F04-412A-A383-21F62A17C377Q36364248-D57AAE9A-716F-447B-93C9-292B03B923CBQ36552289-13E403FD-C737-42F0-ABF1-0F3DC718E714Q36562965-4D5ECCEB-8A55-4A1E-AFF3-7FF4DC280C2AQ36565762-24AA9E40-D95F-4448-A8DE-9E4951222271Q36620257-51CE8C68-D432-47DC-9B39-4147EC9497BCQ36803454-7F751585-7691-47FB-86FE-BBA1846C707FQ36835803-B77E30A8-7656-4042-BC56-7F330BEF39F7Q36933985-A4E81C55-809F-4C53-9774-1BDA86071EB0Q36939547-1F78449A-E8A2-4237-B89C-D62730AC8663Q36951149-F6F88014-ADB9-4915-98F8-08F2E3FA68E1Q37196795-06D32BA0-732A-4182-B994-5C21250419B2Q37207844-E395E083-4611-4640-86CC-A68C5E38C928Q37238265-9549143A-B648-42B0-B4A7-99FF8C2F8C18Q37263818-F5969ACB-6884-48A3-B3EF-4BF9D3207CEAQ37267924-5D0A1EDE-FCE7-4C14-A544-AD6D7E499514Q37366055-10A4A20E-1217-4DEF-86FD-6B436C3661DFQ37550561-D9ADDB59-1D40-40E9-BC12-CF2B80E82A00Q37642833-A91CF491-A9E9-4172-A28B-4A452F6FEAB8Q37695386-7FDF71EE-F143-49F0-9166-B87892758180Q37742091-A9E52A8B-14CA-46B0-A3C6-2DC963EB4750Q37863951-2F75C9FB-AFCC-4D5D-BAE7-73DE440AFAEDQ38047214-3CDD1D2C-CD78-4724-9694-B339EE20AC16Q38084212-9BBBC00F-BE6F-4ED0-B43E-0D88C7E28413
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Drugs in pregnancy. Pharmacokinetics in pregnancy.
@ast
Drugs in pregnancy. Pharmacokinetics in pregnancy.
@en
Drugs in pregnancy. Pharmacokinetics in pregnancy.
@nl
type
label
Drugs in pregnancy. Pharmacokinetics in pregnancy.
@ast
Drugs in pregnancy. Pharmacokinetics in pregnancy.
@en
Drugs in pregnancy. Pharmacokinetics in pregnancy.
@nl
prefLabel
Drugs in pregnancy. Pharmacokinetics in pregnancy.
@ast
Drugs in pregnancy. Pharmacokinetics in pregnancy.
@en
Drugs in pregnancy. Pharmacokinetics in pregnancy.
@nl
P356
P1476
Drugs in pregnancy. Pharmacokinetics in pregnancy.
@en
P2093
Chowienczyk PJ
P304
P356
10.1053/BEOG.2001.0231
P577
2001-12-01T00:00:00Z